

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 8.00769743 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 8.00769743 |
| 3 | interferon-gamma production (GO:0032609) | 7.48891651 |
| 4 | negative T cell selection (GO:0043383) | 6.84162926 |
| 5 | positive thymic T cell selection (GO:0045059) | 6.73081267 |
| 6 | negative thymic T cell selection (GO:0045060) | 6.62270229 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.52013364 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 6.34031443 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.26124377 |
| 10 | response to interleukin-15 (GO:0070672) | 6.26024631 |
| 11 | positive T cell selection (GO:0043368) | 6.00451250 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.95807337 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.95807337 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.89443006 |
| 15 | T cell migration (GO:0072678) | 5.88513667 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.87498584 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.85568482 |
| 18 | thymic T cell selection (GO:0045061) | 5.80778677 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 5.28671877 |
| 20 | leukocyte aggregation (GO:0070486) | 5.28515253 |
| 21 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.14015900 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 5.10341393 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.06564717 |
| 24 | T cell selection (GO:0045058) | 5.02176934 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 4.97827026 |
| 26 | T cell receptor signaling pathway (GO:0050852) | 4.97461995 |
| 27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.69255266 |
| 28 | T cell costimulation (GO:0031295) | 4.57208125 |
| 29 | lymphocyte costimulation (GO:0031294) | 4.48636381 |
| 30 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 4.46660617 |
| 31 | regulation of response to interferon-gamma (GO:0060330) | 4.44310054 |
| 32 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.38491015 |
| 33 | B cell mediated immunity (GO:0019724) | 4.30711266 |
| 34 | detection of bacterium (GO:0016045) | 4.30320329 |
| 35 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.30211223 |
| 36 | T cell differentiation involved in immune response (GO:0002292) | 4.25568151 |
| 37 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.25568151 |
| 38 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.25568151 |
| 39 | regulation of T cell tolerance induction (GO:0002664) | 4.24646803 |
| 40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.18473885 |
| 41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.18473885 |
| 42 | modulation by symbiont of host immune response (GO:0052553) | 4.18473885 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 4.18473885 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 4.18473885 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.18473885 |
| 46 | detection of other organism (GO:0098543) | 4.15534205 |
| 47 | cytidine metabolic process (GO:0046087) | 4.09880386 |
| 48 | cytidine catabolic process (GO:0006216) | 4.09880386 |
| 49 | cytidine deamination (GO:0009972) | 4.09880386 |
| 50 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.01019677 |
| 51 | mast cell activation (GO:0045576) | 3.95405178 |
| 52 | T-helper cell differentiation (GO:0042093) | 3.94733568 |
| 53 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.94733568 |
| 54 | positive regulation of isotype switching (GO:0045830) | 3.94465252 |
| 55 | activated T cell proliferation (GO:0050798) | 3.92642376 |
| 56 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.91430783 |
| 57 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.89806883 |
| 58 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.84096624 |
| 59 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.84096624 |
| 60 | tolerance induction (GO:0002507) | 3.82734429 |
| 61 | sequestering of actin monomers (GO:0042989) | 3.81364306 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.80588309 |
| 63 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.79959724 |
| 64 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.78840568 |
| 65 | alpha-beta T cell differentiation (GO:0046632) | 3.78071606 |
| 66 | alpha-beta T cell activation (GO:0046631) | 3.77394184 |
| 67 | DNA deamination (GO:0045006) | 3.75670968 |
| 68 | neutrophil activation involved in immune response (GO:0002283) | 3.71901960 |
| 69 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.71612045 |
| 70 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.68368418 |
| 71 | B cell receptor signaling pathway (GO:0050853) | 3.65546540 |
| 72 | regulation of cell killing (GO:0031341) | 3.60262118 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.58914387 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.58914387 |
| 75 | response to type I interferon (GO:0034340) | 3.57829061 |
| 76 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.56959602 |
| 77 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.56959602 |
| 78 | mast cell degranulation (GO:0043303) | 3.49096963 |
| 79 | mast cell activation involved in immune response (GO:0002279) | 3.49096963 |
| 80 | T cell differentiation (GO:0030217) | 3.48358544 |
| 81 | leukocyte cell-cell adhesion (GO:0007159) | 3.48010852 |
| 82 | cellular extravasation (GO:0045123) | 3.46861978 |
| 83 | lymphocyte migration (GO:0072676) | 3.46506221 |
| 84 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.45471769 |
| 85 | regulation of B cell differentiation (GO:0045577) | 3.44818146 |
| 86 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.43692213 |
| 87 | positive regulation of B cell mediated immunity (GO:0002714) | 3.43692213 |
| 88 | T cell activation involved in immune response (GO:0002286) | 3.40666026 |
| 89 | positive regulation of cell killing (GO:0031343) | 3.37309340 |
| 90 | positive regulation of DNA recombination (GO:0045911) | 3.36641216 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 3.35434484 |
| 92 | negative regulation of T cell mediated immunity (GO:0002710) | 3.35192718 |
| 93 | macrophage activation involved in immune response (GO:0002281) | 3.34233000 |
| 94 | positive regulation of interleukin-2 production (GO:0032743) | 3.33772888 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.33485535 |
| 96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.32670903 |
| 97 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.31349000 |
| 98 | response to host immune response (GO:0052572) | 3.31177289 |
| 99 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.31177289 |
| 100 | negative regulation of B cell proliferation (GO:0030889) | 3.30443927 |
| 101 | respiratory burst (GO:0045730) | 3.30255639 |
| 102 | regulation of isotype switching (GO:0045191) | 3.28982745 |
| 103 | NIK/NF-kappaB signaling (GO:0038061) | 3.28638049 |
| 104 | regulation of mast cell degranulation (GO:0043304) | 3.28045840 |
| 105 | T cell activation (GO:0042110) | 3.26648805 |
| 106 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.26279366 |
| 107 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.25413442 |
| 108 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.24138760 |
| 109 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.23559413 |
| 110 | positive regulation of granulocyte differentiation (GO:0030854) | 3.19540519 |
| 111 | heterotypic cell-cell adhesion (GO:0034113) | 3.19004606 |
| 112 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.17481447 |
| 113 | positive regulation of tolerance induction (GO:0002645) | 3.17057083 |
| 114 | positive regulation of defense response to virus by host (GO:0002230) | 3.16714612 |
| 115 | natural killer cell activation (GO:0030101) | 3.15257887 |
| 116 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13269011 |
| 117 | negative regulation of interleukin-12 production (GO:0032695) | 3.13183401 |
| 118 | detection of external biotic stimulus (GO:0098581) | 3.11735033 |
| 119 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10835129 |
| 120 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.10631151 |
| 121 | myeloid cell activation involved in immune response (GO:0002275) | 3.10395562 |
| 122 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.09913981 |
| 123 | regulation of B cell mediated immunity (GO:0002712) | 3.09786106 |
| 124 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09746280 |
| 125 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.09696845 |
| 126 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.09619684 |
| 127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09528293 |
| 128 | negative regulation of phagocytosis (GO:0050765) | 3.08793743 |
| 129 | response to peptidoglycan (GO:0032494) | 3.07520474 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.06266020 |
| 131 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.05758939 |
| 132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.05175921 |
| 133 | defense response to protozoan (GO:0042832) | 3.04765941 |
| 134 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04467489 |
| 135 | neutrophil activation (GO:0042119) | 3.02714581 |
| 136 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.02457817 |
| 137 | regulation of tolerance induction (GO:0002643) | 3.02082808 |
| 138 | positive regulation of humoral immune response (GO:0002922) | 3.01717382 |
| 139 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00160248 |
| 140 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99830188 |
| 141 | response to host (GO:0075136) | 2.99830188 |
| 142 | response to host defenses (GO:0052200) | 2.99830188 |
| 143 | positive regulation of T cell activation (GO:0050870) | 2.97111327 |
| 144 | response to protozoan (GO:0001562) | 2.95034991 |
| 145 | regulation of leukocyte degranulation (GO:0043300) | 2.94824990 |
| 146 | leukocyte tethering or rolling (GO:0050901) | 2.94634208 |
| 147 | negative regulation of innate immune response (GO:0045824) | 2.94476290 |
| 148 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.94382630 |
| 149 | positive regulation of T cell differentiation (GO:0045582) | 2.93601473 |
| 150 | positive regulation of immunoglobulin production (GO:0002639) | 2.93543689 |
| 151 | leukocyte degranulation (GO:0043299) | 2.91162887 |
| 152 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.90610844 |
| 153 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89270441 |
| 154 | positive regulation of B cell activation (GO:0050871) | 2.87220525 |
| 155 | regulation of B cell apoptotic process (GO:0002902) | 2.87054948 |
| 156 | positive regulation of interleukin-17 production (GO:0032740) | 2.86266901 |
| 157 | T-helper 1 type immune response (GO:0042088) | 2.85993932 |
| 158 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.85030306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.82603479 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.05285371 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.33844315 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.78684747 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.75585521 |
| 6 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.55959262 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.55562553 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.42491507 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.39009909 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.37622377 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.36914700 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25257389 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.16125075 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.01663269 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.98986493 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83168874 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.78447089 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.73566299 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62757653 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.62489889 |
| 21 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.51718531 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50713775 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.41632658 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35484036 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33007882 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21377114 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.20603019 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.17415075 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06367734 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05445206 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05080866 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 2.02164201 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.02024436 |
| 34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.00665888 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.00597299 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93513114 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89840229 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81100435 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79132424 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78270992 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.76192124 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70722704 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64629605 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64394769 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52811153 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52676480 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50349643 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48683943 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48439043 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44944733 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41486082 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38204074 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36492144 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35852212 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35554651 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29779173 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27641337 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26101174 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25709168 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24993257 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23947220 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23589739 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22723172 |
| 64 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22627450 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21311748 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21220237 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19210123 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18461654 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17945700 |
| 70 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.15396396 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13828814 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.12408500 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11728690 |
| 74 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.08958491 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08756345 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08426781 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07478936 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04500952 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02664062 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02530656 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01977844 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01873624 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01002095 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00465385 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99691598 |
| 86 | P300_27268052_Chip-Seq_Bcells_Human | 0.97464875 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97063867 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93177837 |
| 89 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.93153946 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92277084 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90195933 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89910473 |
| 93 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89862509 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88230195 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87759883 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87409721 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86865284 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86855180 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86789630 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86470768 |
| 101 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85139007 |
| 102 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.80634619 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80389836 |
| 104 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80137501 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79596109 |
| 106 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79372982 |
| 107 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79286140 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76962816 |
| 109 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76850378 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74420838 |
| 111 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74242688 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71044746 |
| 113 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.70339036 |
| 114 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.68613994 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68581433 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68076343 |
| 117 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.66900919 |
| 118 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.65626494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.75318680 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.46472531 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.42072049 |
| 4 | MP0000685_abnormal_immune_system | 3.90495677 |
| 5 | MP0001800_abnormal_humoral_immune | 3.44941048 |
| 6 | MP0001790_abnormal_immune_system | 3.21691065 |
| 7 | MP0005387_immune_system_phenotype | 3.21691065 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.06040239 |
| 9 | MP0002723_abnormal_immune_serum | 2.99993275 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.97631472 |
| 11 | MP0001819_abnormal_immune_cell | 2.94603597 |
| 12 | MP0009785_altered_susceptibility_to | 2.88373052 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.88051958 |
| 14 | MP0002398_abnormal_bone_marrow | 2.74093768 |
| 15 | MP0001873_stomach_inflammation | 2.71978545 |
| 16 | MP0002405_respiratory_system_inflammati | 2.70800544 |
| 17 | MP0005025_abnormal_response_to | 2.64294168 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.50804123 |
| 19 | MP0004510_myositis | 2.47857532 |
| 20 | MP0000716_abnormal_immune_system | 2.47288399 |
| 21 | MP0003724_increased_susceptibility_to | 2.45307389 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.42920777 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.42565050 |
| 24 | MP0003436_decreased_susceptibility_to | 2.40641711 |
| 25 | MP0002722_abnormal_immune_system | 2.32397600 |
| 26 | MP0002419_abnormal_innate_immunity | 2.32115441 |
| 27 | MP0010155_abnormal_intestine_physiology | 2.29873899 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.16529247 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.11145333 |
| 30 | MP0002006_tumorigenesis | 2.09394077 |
| 31 | MP0004947_skin_inflammation | 2.06826098 |
| 32 | MP0001853_heart_inflammation | 2.05670214 |
| 33 | MP0002429_abnormal_blood_cell | 2.01309624 |
| 34 | MP0003866_abnormal_defecation | 1.94631759 |
| 35 | MP0003303_peritoneal_inflammation | 1.94421350 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.91955766 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.88136973 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.84785748 |
| 39 | MP0002933_joint_inflammation | 1.84135672 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.75101844 |
| 41 | MP0000858_altered_metastatic_potential | 1.71394357 |
| 42 | MP0006082_CNS_inflammation | 1.70231881 |
| 43 | MP0005310_abnormal_salivary_gland | 1.69300403 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.51623106 |
| 45 | MP0003448_altered_tumor_morphology | 1.36882630 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.35177397 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.32074586 |
| 48 | MP0008469_abnormal_protein_level | 1.20741977 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.19709985 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.19049222 |
| 51 | MP0002693_abnormal_pancreas_physiology | 1.18111213 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.12595116 |
| 53 | MP0001851_eye_inflammation | 1.10571310 |
| 54 | MP0003787_abnormal_imprinting | 1.10416669 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.08010451 |
| 56 | MP0005451_abnormal_body_composition | 1.06013671 |
| 57 | MP0003075_altered_response_to | 1.05410227 |
| 58 | MP0000490_abnormal_crypts_of | 1.04620893 |
| 59 | MP0004381_abnormal_hair_follicle | 1.03862668 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.01394173 |
| 61 | MP0003045_fibrosis | 0.96642343 |
| 62 | MP0001545_abnormal_hematopoietic_system | 0.92922608 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 0.92922608 |
| 64 | MP0002019_abnormal_tumor_incidence | 0.92894310 |
| 65 | MP0005174_abnormal_tail_pigmentation | 0.91616592 |
| 66 | MP0009764_decreased_sensitivity_to | 0.89230037 |
| 67 | MP0002998_abnormal_bone_remodeling | 0.87584493 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 0.86663102 |
| 69 | MP0002009_preneoplasia | 0.86642000 |
| 70 | MP0008961_abnormal_basal_metabolism | 0.85628009 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 0.83300008 |
| 72 | MP0001986_abnormal_taste_sensitivity | 0.79384761 |
| 73 | MP0005023_abnormal_wound_healing | 0.79328541 |
| 74 | MP0002163_abnormal_gland_morphology | 0.78261628 |
| 75 | MP0000343_altered_response_to | 0.77087029 |
| 76 | MP0009278_abnormal_bone_marrow | 0.75942849 |
| 77 | MP0002132_abnormal_respiratory_system | 0.74219027 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.73312465 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.72944143 |
| 80 | MP0008260_abnormal_autophagy | 0.72338014 |
| 81 | MP0009763_increased_sensitivity_to | 0.72220640 |
| 82 | MP0004883_abnormal_blood_vessel | 0.71748583 |
| 83 | MP0005076_abnormal_cell_differentiation | 0.71651248 |
| 84 | MP0008057_abnormal_DNA_replication | 0.70989675 |
| 85 | MP0000609_abnormal_liver_physiology | 0.70946204 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.69122889 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.68821193 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.67165075 |
| 89 | MP0008877_abnormal_DNA_methylation | 0.67056954 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.66951788 |
| 91 | MP0010307_abnormal_tumor_latency | 0.66519682 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.65591669 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.63254316 |
| 94 | MP0000477_abnormal_intestine_morphology | 0.60703819 |
| 95 | MP0005379_endocrine/exocrine_gland_phen | 0.60011745 |
| 96 | MP0001243_abnormal_dermal_layer | 0.59822665 |
| 97 | MP0003828_pulmonary_edema | 0.58800068 |
| 98 | MP0003690_abnormal_glial_cell | 0.58461165 |
| 99 | MP0000249_abnormal_blood_vessel | 0.57884890 |
| 100 | MP0003191_abnormal_cellular_cholesterol | 0.57642219 |
| 101 | MP0001663_abnormal_digestive_system | 0.56636413 |
| 102 | MP0003077_abnormal_cell_cycle | 0.56042007 |
| 103 | MP0008874_decreased_physiological_sensi | 0.55287502 |
| 104 | MP0005535_abnormal_body_temperature | 0.53283124 |
| 105 | MP0009642_abnormal_blood_homeostasis | 0.52875347 |
| 106 | MP0002139_abnormal_hepatobiliary_system | 0.51965353 |
| 107 | MP0003786_premature_aging | 0.51862969 |
| 108 | MP0001881_abnormal_mammary_gland | 0.51565722 |
| 109 | MP0003795_abnormal_bone_structure | 0.49996583 |
| 110 | MP0003638_abnormal_response/metabolism_ | 0.49877139 |
| 111 | MP0003252_abnormal_bile_duct | 0.48838659 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.48817737 |
| 113 | MP0005220_abnormal_exocrine_pancreas | 0.48219589 |
| 114 | MP0003943_abnormal_hepatobiliary_system | 0.46775461 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.46637833 |
| 116 | MP0000604_amyloidosis | 0.45900598 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.45425866 |
| 118 | MP0005166_decreased_susceptibility_to | 0.44679371 |
| 119 | MP0008873_increased_physiological_sensi | 0.44115663 |
| 120 | MP0002928_abnormal_bile_duct | 0.44076140 |
| 121 | MP0008007_abnormal_cellular_replicative | 0.43961002 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 0.43739327 |
| 123 | MP0003091_abnormal_cell_migration | 0.43167208 |
| 124 | MP0005390_skeleton_phenotype | 0.42846531 |
| 125 | MP0003693_abnormal_embryo_hatching | 0.42360130 |
| 126 | MP0004957_abnormal_blastocyst_morpholog | 0.40739679 |
| 127 | MP0000367_abnormal_coat/_hair | 0.39421955 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.39256413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.64802101 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.23618679 |
| 3 | Myositis (HP:0100614) | 5.71133865 |
| 4 | Combined immunodeficiency (HP:0005387) | 5.46460352 |
| 5 | Abnormality of T cells (HP:0002843) | 5.34771064 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 5.26035197 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.14510152 |
| 8 | IgM deficiency (HP:0002850) | 4.87420820 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.72743001 |
| 10 | Optic neuritis (HP:0100653) | 4.72743001 |
| 11 | Orchitis (HP:0100796) | 4.46791398 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.45240645 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.32358464 |
| 14 | Stomatitis (HP:0010280) | 4.24552406 |
| 15 | Nasal polyposis (HP:0100582) | 4.20772662 |
| 16 | Recurrent viral infections (HP:0004429) | 4.20157763 |
| 17 | Thyroiditis (HP:0100646) | 4.19370716 |
| 18 | Pustule (HP:0200039) | 4.13778179 |
| 19 | Abnormality of macrophages (HP:0004311) | 4.13413338 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.97741595 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.92319248 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.91122127 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.81182135 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.79141693 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.79141693 |
| 26 | Chronic otitis media (HP:0000389) | 3.75094968 |
| 27 | Abnormality of eosinophils (HP:0001879) | 3.70398673 |
| 28 | Chronic diarrhea (HP:0002028) | 3.68000107 |
| 29 | IgG deficiency (HP:0004315) | 3.64847349 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 3.54392065 |
| 31 | Urticaria (HP:0001025) | 3.51161354 |
| 32 | Keratoconjunctivitis sicca (HP:0001097) | 3.50926884 |
| 33 | Inflammation of the large intestine (HP:0002037) | 3.43129432 |
| 34 | Hypochromic anemia (HP:0001931) | 3.41376474 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.35101762 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.33806553 |
| 37 | Gastrointestinal inflammation (HP:0004386) | 3.31044082 |
| 38 | Meningitis (HP:0001287) | 3.29904836 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 3.28153741 |
| 40 | Gastrointestinal stroma tumor (HP:0100723) | 3.26953749 |
| 41 | Encephalitis (HP:0002383) | 3.25875321 |
| 42 | Leukocytosis (HP:0001974) | 3.22576895 |
| 43 | Abnormality of the fingertips (HP:0001211) | 3.21377452 |
| 44 | Recurrent skin infections (HP:0001581) | 3.15971116 |
| 45 | Keratoconjunctivitis (HP:0001096) | 3.15894704 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 3.12949521 |
| 47 | Spontaneous hematomas (HP:0007420) | 3.10976219 |
| 48 | Hemoptysis (HP:0002105) | 3.08003135 |
| 49 | Joint swelling (HP:0001386) | 2.98218220 |
| 50 | Vasculitis (HP:0002633) | 2.97453097 |
| 51 | Increased density of long bones (HP:0006392) | 2.97352606 |
| 52 | Arterial thrombosis (HP:0004420) | 2.86358442 |
| 53 | Lymphopenia (HP:0001888) | 2.86264190 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.85044893 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.84769552 |
| 56 | Gastrointestinal infarctions (HP:0005244) | 2.83969512 |
| 57 | Agammaglobulinemia (HP:0004432) | 2.82300169 |
| 58 | Eosinophilia (HP:0001880) | 2.79917623 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.79236768 |
| 60 | Obstructive lung disease (HP:0006536) | 2.79236768 |
| 61 | Recurrent sinusitis (HP:0011108) | 2.75988676 |
| 62 | Osteomyelitis (HP:0002754) | 2.75950806 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.72077980 |
| 64 | IgA deficiency (HP:0002720) | 2.68294856 |
| 65 | Increased IgM level (HP:0003496) | 2.67634976 |
| 66 | Colitis (HP:0002583) | 2.62903990 |
| 67 | Sepsis (HP:0100806) | 2.61807718 |
| 68 | Increased IgE level (HP:0003212) | 2.61670172 |
| 69 | Abnormality of B cell number (HP:0010975) | 2.61637302 |
| 70 | B lymphocytopenia (HP:0010976) | 2.61637302 |
| 71 | Pulmonary embolism (HP:0002204) | 2.54323712 |
| 72 | Granulocytopenia (HP:0001913) | 2.44813895 |
| 73 | Abnormality of the prostate (HP:0008775) | 2.43156259 |
| 74 | Bronchitis (HP:0012387) | 2.41553192 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.37016264 |
| 76 | Lymphoma (HP:0002665) | 2.32359658 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.31222017 |
| 78 | Epistaxis (HP:0000421) | 2.30463737 |
| 79 | Acute hepatic failure (HP:0006554) | 2.29298315 |
| 80 | Gingivitis (HP:0000230) | 2.24358600 |
| 81 | Recurrent lower respiratory tract infections (HP:0002783) | 2.24340803 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.23324259 |
| 83 | Skin rash (HP:0000988) | 2.21746619 |
| 84 | Hematochezia (HP:0002573) | 2.21597193 |
| 85 | Viral hepatitis (HP:0006562) | 2.21340407 |
| 86 | Anorexia (HP:0002039) | 2.20992700 |
| 87 | Petechiae (HP:0000967) | 2.20673921 |
| 88 | Papilloma (HP:0012740) | 2.19765077 |
| 89 | Verrucae (HP:0200043) | 2.19765077 |
| 90 | Neonatal hypoglycemia (HP:0001998) | 2.17618157 |
| 91 | Hypochromic microcytic anemia (HP:0004840) | 2.14545970 |
| 92 | Thrombocytosis (HP:0001894) | 2.13488014 |
| 93 | Gangrene (HP:0100758) | 2.12821813 |
| 94 | Gingival bleeding (HP:0000225) | 2.12774906 |
| 95 | Persistence of primary teeth (HP:0006335) | 2.11960412 |
| 96 | Recurrent pneumonia (HP:0006532) | 2.11029313 |
| 97 | Hypoplasia of the thymus (HP:0000778) | 2.10311461 |
| 98 | Restrictive lung disease (HP:0002091) | 2.08883969 |
| 99 | Abnormal platelet volume (HP:0011876) | 2.01842836 |
| 100 | Neutropenia (HP:0001875) | 2.01783861 |
| 101 | Chest pain (HP:0100749) | 2.00625345 |
| 102 | Basal cell carcinoma (HP:0002671) | 1.98596607 |
| 103 | Frequent falls (HP:0002359) | 1.97360953 |
| 104 | Interstitial pulmonary disease (HP:0006530) | 1.96798415 |
| 105 | Spondylolisthesis (HP:0003302) | 1.94838760 |
| 106 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.94534516 |
| 107 | Recurrent otitis media (HP:0000403) | 1.93372721 |
| 108 | Increased CSF protein (HP:0002922) | 1.92564857 |
| 109 | Skin ulcer (HP:0200042) | 1.91329719 |
| 110 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90187531 |
| 111 | Episodic fever (HP:0001954) | 1.89112833 |
| 112 | Microcytic anemia (HP:0001935) | 1.88330228 |
| 113 | Polyneuropathy (HP:0001271) | 1.84973558 |
| 114 | Abnormality of the pleura (HP:0002103) | 1.83903181 |
| 115 | Abnormality of the endocardium (HP:0004306) | 1.83454682 |
| 116 | Cellulitis (HP:0100658) | 1.82446934 |
| 117 | Periodontitis (HP:0000704) | 1.81953493 |
| 118 | Cheilitis (HP:0100825) | 1.80460098 |
| 119 | Bronchiectasis (HP:0002110) | 1.78800120 |
| 120 | Arthralgia (HP:0002829) | 1.78365570 |
| 121 | Keratitis (HP:0000491) | 1.77317965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.96201300 |
| 2 | MAP4K1 | 5.81846558 |
| 3 | ZAP70 | 3.20182826 |
| 4 | ITK | 3.18751650 |
| 5 | JAK3 | 2.68829364 |
| 6 | GRK6 | 2.62277019 |
| 7 | STK10 | 2.52209046 |
| 8 | JAK1 | 2.43125244 |
| 9 | TYK2 | 2.37439701 |
| 10 | BLK | 2.24126540 |
| 11 | IKBKE | 2.20158859 |
| 12 | FGFR4 | 2.15879218 |
| 13 | MAP3K14 | 2.15082744 |
| 14 | PRPF4B | 2.10043117 |
| 15 | TLK1 | 2.08330473 |
| 16 | TESK2 | 2.06839588 |
| 17 | MAP3K13 | 2.00034909 |
| 18 | EEF2K | 1.81726654 |
| 19 | TAOK3 | 1.79628220 |
| 20 | TBK1 | 1.76978074 |
| 21 | CSK | 1.72612687 |
| 22 | MAP3K12 | 1.72466404 |
| 23 | NLK | 1.69669613 |
| 24 | LCK | 1.63829180 |
| 25 | TEC | 1.57338872 |
| 26 | FGFR3 | 1.57220712 |
| 27 | CDK19 | 1.56667868 |
| 28 | SYK | 1.54214482 |
| 29 | BTK | 1.47974314 |
| 30 | MST4 | 1.40214775 |
| 31 | MAP3K10 | 1.39036394 |
| 32 | KDR | 1.36952055 |
| 33 | MAP3K11 | 1.36410684 |
| 34 | IKBKB | 1.35343552 |
| 35 | IRAK3 | 1.34593006 |
| 36 | IRAK4 | 1.31906461 |
| 37 | HCK | 1.30445415 |
| 38 | KIT | 1.25227301 |
| 39 | PIK3CA | 1.18458725 |
| 40 | EPHB1 | 1.08848571 |
| 41 | PIM1 | 1.06433599 |
| 42 | MAPK12 | 1.00949879 |
| 43 | LRRK2 | 1.00838457 |
| 44 | PKN2 | 1.00630381 |
| 45 | MARK3 | 1.00244972 |
| 46 | STK24 | 0.99493481 |
| 47 | SIK2 | 0.98811516 |
| 48 | SMG1 | 0.98205781 |
| 49 | TGFBR2 | 0.97096494 |
| 50 | CDC42BPA | 0.94276310 |
| 51 | PRKCH | 0.92304501 |
| 52 | CHUK | 0.90311048 |
| 53 | MATK | 0.89913684 |
| 54 | CSF1R | 0.89772273 |
| 55 | PRKCQ | 0.86090751 |
| 56 | LYN | 0.85155457 |
| 57 | CLK1 | 0.81391757 |
| 58 | TSSK6 | 0.81127749 |
| 59 | MAP3K1 | 0.76376083 |
| 60 | FES | 0.75587745 |
| 61 | PIK3CG | 0.74214461 |
| 62 | JAK2 | 0.73609551 |
| 63 | RPS6KA4 | 0.72906404 |
| 64 | FLT3 | 0.70829323 |
| 65 | TNK2 | 0.69124314 |
| 66 | MAP2K3 | 0.64307259 |
| 67 | PDGFRB | 0.64005091 |
| 68 | PASK | 0.63324563 |
| 69 | MAP3K7 | 0.63209721 |
| 70 | RET | 0.62875421 |
| 71 | CDK4 | 0.62276448 |
| 72 | MAP3K3 | 0.61818526 |
| 73 | SIK3 | 0.61301923 |
| 74 | EPHA3 | 0.60582230 |
| 75 | PDPK1 | 0.59435227 |
| 76 | TRIB3 | 0.58829794 |
| 77 | MELK | 0.58467307 |
| 78 | GRK7 | 0.58413225 |
| 79 | TESK1 | 0.57073053 |
| 80 | FRK | 0.56478136 |
| 81 | MAP3K5 | 0.54559367 |
| 82 | BCKDK | 0.54454894 |
| 83 | FGFR1 | 0.53453090 |
| 84 | CDK12 | 0.52843964 |
| 85 | YES1 | 0.51580738 |
| 86 | MAPK7 | 0.49693282 |
| 87 | PRKD2 | 0.49091245 |
| 88 | CAMKK2 | 0.48786511 |
| 89 | DMPK | 0.47154356 |
| 90 | EIF2AK1 | 0.45231200 |
| 91 | FYN | 0.44387182 |
| 92 | OXSR1 | 0.44087766 |
| 93 | PDK1 | 0.42813646 |
| 94 | MAP3K6 | 0.41453640 |
| 95 | ALK | 0.40212572 |
| 96 | PTK2B | 0.39582270 |
| 97 | ERN1 | 0.39485464 |
| 98 | BMPR2 | 0.39452641 |
| 99 | RPS6KB2 | 0.38641359 |
| 100 | TTN | 0.37173233 |
| 101 | MARK2 | 0.37120246 |
| 102 | TAOK1 | 0.36986673 |
| 103 | HIPK2 | 0.36454925 |
| 104 | SIK1 | 0.35861222 |
| 105 | INSR | 0.34415443 |
| 106 | MAPKAPK2 | 0.34360994 |
| 107 | PAK4 | 0.33375265 |
| 108 | CAMKK1 | 0.33192097 |
| 109 | MAP2K6 | 0.32731376 |
| 110 | IRAK1 | 0.32574722 |
| 111 | MAPK15 | 0.31473358 |
| 112 | TRPM7 | 0.30897483 |
| 113 | NME2 | 0.30547825 |
| 114 | MYLK | 0.29874748 |
| 115 | STK11 | 0.29680777 |
| 116 | FGR | 0.29650376 |
| 117 | MAP3K8 | 0.28270205 |
| 118 | STK4 | 0.27582353 |
| 119 | EIF2AK3 | 0.26581415 |
| 120 | DAPK2 | 0.26101182 |
| 121 | MAPKAPK3 | 0.24582192 |
| 122 | ABL1 | 0.24528986 |
| 123 | CDK9 | 0.24132663 |
| 124 | SCYL2 | 0.23659952 |
| 125 | IGF1R | 0.23496602 |
| 126 | MAP2K2 | 0.22943054 |
| 127 | MAPK11 | 0.21852779 |
| 128 | PTK6 | 0.20744994 |
| 129 | TYRO3 | 0.20728566 |
| 130 | PRKD1 | 0.20348485 |
| 131 | PRKCD | 0.20261784 |
| 132 | RIPK4 | 0.19355120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.04652904 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.74736173 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.71854903 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.34638969 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.33270123 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.02919216 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.83458165 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71820546 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.68112250 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44780670 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36630427 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18409197 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.12345155 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.06981904 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.96667445 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64002457 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58564216 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57225544 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.56441848 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55796050 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.54179914 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50271199 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40027089 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39268462 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38946609 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.38394153 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.36195812 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30345832 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27804310 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26763740 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.22552332 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21023556 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.20358565 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19580634 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.13601928 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11884794 |
| 37 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05044738 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.02254070 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01946313 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00070764 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99627234 |
| 42 | Colorectal cancer_Homo sapiens_hsa05210 | 0.98964431 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95473639 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94863713 |
| 45 | Malaria_Homo sapiens_hsa05144 | 0.90075777 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 0.89381194 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 0.87718197 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87034628 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84131553 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.83886938 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81107369 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80956356 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80181231 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76646007 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75956710 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.75523763 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.75132323 |
| 58 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74023818 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71889445 |
| 60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67778171 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.64898049 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.63435017 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61404972 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61294271 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.60517748 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60131790 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59888029 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53394800 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51982438 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51412058 |
| 71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49753890 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49065490 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.48907737 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48596364 |
| 75 | Spliceosome_Homo sapiens_hsa03040 | 0.46686539 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.44464754 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44371043 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42558671 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42246390 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42000917 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39206720 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.38409847 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38132446 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37308117 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34825627 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34706261 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33428673 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33347941 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32800270 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32712368 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32212654 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31735535 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31685523 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.30900748 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30086124 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29757871 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.29328463 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28152521 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28020073 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25190791 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.24435498 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24411731 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23830016 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.23505364 |
| 105 | Base excision repair_Homo sapiens_hsa03410 | 0.21834949 |
| 106 | Focal adhesion_Homo sapiens_hsa04510 | 0.21448543 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20212050 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.19701910 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19421290 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19290071 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18814269 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17691901 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16921986 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15491811 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13725908 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.12841063 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10314832 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.05746148 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.03705519 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.03602056 |

